LYC Healthcare Berhad Past Earnings Performance

Past criteria checks 0/6

LYC Healthcare Berhad's earnings have been declining at an average annual rate of -16%, while the IT industry saw earnings growing at 25.8% annually. Revenues have been growing at an average rate of 51.6% per year.

Key information

-16.0%

Earnings growth rate

-0.09%

EPS growth rate

IT Industry Growth25.8%
Revenue growth rate51.6%
Return on equity-14.7%
Net Margin-14.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Apr 30
LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Nov 01
Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 14
LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jul 04
Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Mar 26
Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Feb 01
LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Sep 15
It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

Sep 10
Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

May 11
Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Nov 29
Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jun 13
Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Mar 01
How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Revenue & Expenses Breakdown
Beta

How LYC Healthcare Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:LYC Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23121-17660
30 Sep 23108-17550
30 Jun 2398-17440
31 Mar 2392-19400
31 Dec 2286-12350
30 Sep 2284-12350
30 Jun 2274-11340
31 Mar 2265-9320
31 Dec 2158-11290
30 Sep 2144-12260
30 Jun 2135-12230
31 Mar 2126-12190
31 Dec 2016-14180
30 Sep 2013-12140
30 Jun 2012-11130
31 Mar 2012-10120
31 Dec 1912-8100
30 Sep 1910-8100
30 Jun 196-890
31 Mar 198-890
31 Dec 186-780
30 Sep 186-670
30 Jun 187-460
31 Mar 186-350
31 Mar 1733-270
30 Sep 1635-170
30 Jun 1639-180
31 Mar 1642-280
31 Dec 1540-290
30 Sep 1540-290
30 Jun 1543090
31 Mar 1544090
31 Dec 1443-1100
30 Sep 1441-280
30 Jun 1433-380
31 Mar 1432-390
31 Dec 1333-390
30 Sep 1334-3100
30 Jun 1336-3100

Quality Earnings: LYC is currently unprofitable.

Growing Profit Margin: LYC is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LYC is unprofitable, and losses have increased over the past 5 years at a rate of 16% per year.

Accelerating Growth: Unable to compare LYC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LYC is unprofitable, making it difficult to compare its past year earnings growth to the IT industry (18.7%).


Return on Equity

High ROE: LYC has a negative Return on Equity (-14.74%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.